These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6288407)

  • 21. [3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain.
    Rehavi M; Tracer H; Rice K; Skolnick P; Paul SM
    Life Sci; 1983 Feb; 32(6):645-53. PubMed ID: 6835029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noradrenergic and serotonergic input necessary for imipramine-induced changes in beta but not S2 receptor densities.
    Dumbrille-Ross A; Tang SW
    Psychiatry Res; 1983 Jul; 9(3):207-15. PubMed ID: 6312480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes.
    Mellerup ET; Plenge P
    Psychopharmacology (Berl); 1986; 89(4):436-9. PubMed ID: 2944152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased high affinity 3H-imipramine binding in platelets of enuretic children and adolescents.
    Weizman A; Carel C; Tyano S; Rehavi M
    Psychiatry Res; 1985 Jan; 14(1):39-46. PubMed ID: 3857647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic properties of [3H]2-nitroimipramine binding to human platelets.
    Davis A
    Eur J Pharmacol; 1983 Dec; 96(1-2):105-10. PubMed ID: 6662191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression.
    Papp M; Klimek V; Willner P
    Psychopharmacology (Berl); 1994 Mar; 114(2):309-14. PubMed ID: 7838924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specification of 3H-imipramine bindings on human platelets and in rat hypothalamus.
    Krpálek P; Zácková P
    Act Nerv Super (Praha); 1989 Dec; 31(4):285-6. PubMed ID: 2638114
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors.
    Poirier MF; Benkelfat C; Loo H; Sechter D; Zarifian E; Galzin AM; Langer SZ
    Psychopharmacology (Berl); 1986; 89(4):456-61. PubMed ID: 3092276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localisation of tricyclic antidepressant binding sites on serotonin nerve terminals.
    Sette M; Raisman R; Briley M; Langer SZ
    J Neurochem; 1981 Jul; 37(1):40-2. PubMed ID: 7252512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns.
    Duncan GE; Little KY; Kirkman JA; Kaldas RS; Stumpf WE; Breese GR
    Brain Res; 1992 Sep; 591(2):181-97. PubMed ID: 1332802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
    Weizman A; Carmi M; Hermesh H; Shahar A; Apter A; Tyano S; Rehavi M
    Am J Psychiatry; 1986 Mar; 143(3):335-9. PubMed ID: 3006522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlorimipramine--but not imipramine--rapidly reduces [3H]imipramine binding in human platelet membranes.
    Mellerup ET; Plenge P
    Eur J Pharmacol; 1986 Jul; 126(1-2):155-8. PubMed ID: 3758160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo inhibition of [3H]imipramine binding by cadmium.
    Peterson LL; Bartfai T
    Eur J Pharmacol; 1983 Jun; 90(2-3):289-92. PubMed ID: 6873187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced displacement of [3H]imipramine, but not [3H]paroxetine binding by plasma from depressed patients.
    Lawrence KM; Lowther S; Falkowski J; Jacobson RR; Horton RW
    J Affect Disord; 1997 Nov; 46(2):127-34. PubMed ID: 9479616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors.
    Gandolfi O; Barbaccia ML; Costa E
    J Pharmacol Exp Ther; 1984 Jun; 229(3):782-6. PubMed ID: 6327970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites.
    Duncan GE; Paul IA; Powell KR; Fassberg JB; Stumpf WE; Breese GR
    J Pharmacol Exp Ther; 1989 Jan; 248(1):470-7. PubMed ID: 2536433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation by electroshock treatment of the haloperidol-induced rise in the binding of 3H-imipramine to rat brain membranes.
    Barkai AI; Kowalik S; Reches A; Cooper TB; Fahn S
    Psychopharmacology (Berl); 1985; 86(4):400-3. PubMed ID: 3929309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.
    Poirier MF; Loo H; Benkelfat C; Sechter D; Zarifian E; Galzin AM; Schoemaker H; Segonzac A; Langer SZ
    Eur J Pharmacol; 1984 Nov; 106(3):629-33. PubMed ID: 6097464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tricyclic antidepressants and calcium channel blockers: interactions at the (-)-desmethoxyverapamil binding site and the serotonin transporter.
    Rehavi M; Carmi R; Weizman A
    Eur J Pharmacol; 1988 Oct; 155(1-2):1-9. PubMed ID: 2854066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.